Real-world impact of fremanezumab on migraine symptoms and resource utilization in the United States
{{output}}
Background: Fremanezumab, a fully humanized monoclonal antibody (IgG2Δa) that selectively targets calcitonin gene-related peptide (CGRP), is approved for migraine prevention in adults. Real-world data on the effectiveness of fre... ...
